Vancomycin

Glycopeptide AntibioticRx: PrescriptionCompound: Approved

Also known as: Firvanq, Lyphocin, VAN, Vancocin, Vancocin HCl, Vancoled, Vancomycin hydrochloride

Educational Only — Not medical advice. Consult a qualified clinician before using any peptide.

Source Vancomycin at Peptiology

Save 10% with code PEPTI-BOSSRABBIT-10

Shop Now & Save 10% →

Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.

Summary

Vancomycin is a clinically approved glycopeptide used intravenously for serious Gram‑positive infections (e.g., MRSA, enterococcal infections) and orally for Clostridioides difficile colitis.

Mechanism of Action

Binds the D-Ala-D-Ala terminus of peptidoglycan precursors, blocking transglycosylation and transpeptidation and thereby inhibiting bacterial cell‑wall synthesis

Routes of Administration

IntrathecalIntravenousOralTopical

Goals & Uses

  • Treatment of enterococcal infectionsAntimicrobial TherapyHigh
  • Surgical prophylaxis in beta-lactam allergic patientsProphylaxisModerate
  • Treatment of C. difficile colitisInfectionHigh
  • Treatment of MRSA infectionsAntimicrobialHigh
  • Prophylaxis in neutropenic patientsPreventionModerate
  • Treatment of Clostridioides difficile colitisAntimicrobial TherapyHigh
  • Treatment of CNS infections (meningitis)Antimicrobial TherapyModerate

Contraindications

  • Severe pre-existing hearing lossOtotoxicity RiskModerate
  • Known hypersensitivity to vancomycinAllergyHigh
  • Hypersensitivity to vancomycinAllergyHigh
  • Severe renal impairment with no dose adjustmentRenalModerate
  • Vancomycin-resistant organisms (VRE)Microbial ResistanceHigh

Adverse Effects

  • ThrombophlebitisVascularCommon
  • ThrombocytopeniaHematologicRareLow platelet count
  • OtotoxicityAuditory/vestibularUncommon
  • HypotensionCardiovascularUncommonLow blood pressure
  • Red‑man syndromeInfusion‑relatedCommon
  • Red man syndromeInfusion ReactionCommon
  • NeutropeniaHematologicUncommonLow neutrophil count
  • NephrotoxicityRenalCommon

Drug Interactions

  • AminoglycosidesHigh
  • Neuromuscular blocking agentsModerate
  • Aminoglycosides (e.g., gentamicin, tobramycin)High
  • Piperacillin-tazobactamModerate
  • NSAIDsModerateMay increase renal risk in susceptible patients
  • NSAIDs (e.g., indomethacin)Moderate
  • Loop diuretics (e.g., furosemide)Moderate

Population Constraints

  • Pregnancy (Category C/B2)PregnancyRelative
  • Renal impairmentOrgan ImpairmentRelative
  • ElderlyAgeRelative
  • Elderly patientsAgeRelative
  • Neonates and premature infantsPediatricRelative
  • Pregnant womenReproductiveRelative
  • NeonatesPediatricRelative
  • Hearing-impaired patientsPre Existing ConditionRelative

Regulatory Status

  • European UnionApprovedApproved: Serious Gram‑positive infections, C. difficile colitis (oral)Similar to US
  • United StatesApprovedApproved: Complicated skin and skin‑structure infections, Bacteremia, Endocarditis, Osteomyelitis, C. difficile colitis (oral)IV and oral formulations
  • United KingdomApprovedApproved: Severe Gram‑positive infections, C. difficile colitis

Therapeutic drug monitoring recommended for IV use; monitor renal function and hearing; red‑man syndrome can occur with rapid infusion.

Evidence & Sources

No sources recorded yet.

Frequently Asked Questions

What is Vancomycin?

Vancomycin is a clinically approved glycopeptide used intravenously for serious Gram‑positive infections (e.g., MRSA, enterococcal infections) and orally for Clostridioides difficile colitis.

What is Vancomycin used for?

Vancomycin is educationally associated with: Treatment of enterococcal infections, Surgical prophylaxis in beta-lactam allergic patients, Treatment of C. difficile colitis, Treatment of MRSA infections, Prophylaxis in neutropenic patients, Treatment of Clostridioides difficile colitis, Treatment of CNS infections (meningitis). Educational only — not medical advice.

How is Vancomycin administered?

Recorded routes of administration: Intrathecal, Intravenous, Oral, Topical.

What are the potential side effects of Vancomycin?

Reported adverse effects include: Thrombophlebitis, Thrombocytopenia, Ototoxicity, Hypotension, Red‑man syndrome, Red man syndrome, Neutropenia, Nephrotoxicity. This list is not exhaustive — consult a qualified clinician.

Who should avoid Vancomycin?

Recorded contraindications: Severe pre-existing hearing loss, Known hypersensitivity to vancomycin, Hypersensitivity to vancomycin, Severe renal impairment with no dose adjustment, Vancomycin-resistant organisms (VRE). Consult a qualified clinician before use.

More in this class